Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study
- PMID: 36586169
- DOI: 10.1016/j.leukres.2022.107007
Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study
Keywords: BCOR; CCUS; CHIP; Clonal hematopoiesis; Splicing Genes; U2AF1.
Conflict of interest statement
Declarations of interest Mrinal Patnaik has received research funding from StemLine Pharmaceuticals, Kura Oncology and served on the advisory board for CTI Pharmaceuticals.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
